Targeted maximum likelihood estimation for longitudinal two-stage designs with outcome subsampling
结局子抽样纵向两阶段设计的目标最大似然估计AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要明确以纵向两阶段抽样设计中的因果参数为目标,使用干预节点与目标估计,因此最直接对应因果推断方向。
结局子抽样纵向两阶段设计的目标最大似然估计AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
We consider efficient estimation of causal parameters in longitudinal two-stage designs with outcome subsampling, motivated by resampling designs in HIV-related mortality studies. In these studies, many participants become lost to follow-up; resampling designs address this by tracing a subset of lost individuals to ascertain their outcomes. Analyses often use inverse-probability-weighted Kaplan-Meier (wKM) estimators that discard longitudinal covariate information and suffer from efficiency losses. We note that resampling designs are an instance of a broader class: two-stage designs with outcome subsampling, in which a first stage collects some data on all participants and a second stage collects outcome information on a selected subset. This connection motivates two estimators. First, drawing on inverse probability of censoring weighted targeted maximum likelihood estimation (IPCW-TMLE) for two-stage designs, we develop its longitudinal extension, IPCW longitudinal TMLE (IPCW-LTMLE) and show that estimating and targeting the known second-stage sampling weights yields variance reductions of up to 36% over the use of known sampling probabilities. Second, given that inverse weighting sacrifices efficiency, we propose an LTMLE that incorporates the second-stage sampling indicator as an intervention node in the sequential regression framework, returning to plug-in estimation and avoiding inverse weighting entirely. Simulations across sample sizes show that LTMLE achieves up to 73% lower variance than wKM with known sampling weights, with reductions of 30-50% common across settings, while IPCW-LTMLE achieves consistent gains of 20-35%. We further demonstrate that cross-fitted variance estimation is essential for valid inference: standard variance estimators yield confidence interval coverage as low as 76%, while our cross-fitted variants consistently restore coverage to nominal levels.
广义线性模型中多层模型与固定效应方法的比较
We extend prior work comparing linear multilevel models (MLM) and fixed effect (FE) models to the generalized linear model (GLM) setting, where the coefficient on a treatment variable is of primary interest. This leads to three insights. (i) First, as in the linear setting, MLM can be thought of as a regularized form of FE (RegFE). This explains why group-level confounding can greatly bias MLM's treatment coefficient estimates. However, unlike the linear setting, there is…
群组随机试验分析的最优置换检验
Two facts complicate the comparison of interventions in group randomized trials (GRT's), a family of clinical trials in which each member of a particular group receives the same treatment assignment. First, individual outcomes within each group are often correlated. Second, the number of groups in a GRT is often not sufficient to make asymptotic approximations possible. Therefore, the tests used with methods, such as generalized estimating equations (GEE) and penalized quasi…
靶向深度生存对比:神经网络下处理特定生存收益的有效推断
Neural survival models are increasingly asked to support counterfactual claims---how much a treatment would change survival in a population---rather than only prognostic risk scores. Answering such questions from observational data requires valid inference for treatment-specific survival contrasts under confounding and covariate-dependent censoring, targets for which standard deep survival estimators are biased and provide no honest uncertainty. We propose Targeted Deep…
调查抽样与因果推断中的最优控制变量
We propose a family of control variate estimators for variance reduction in design-based survey sampling and causal inference, with and without interference. In these settings, inverse probability weighting (IPW) estimators are widely used, but may have large variance when sampling, treatment, or exposure probabilities are small. Building on the observation that several common estimators, including the Hajek estimator, the normalized estimator, the augmented inverse…
用联合校准权重改进目标试验模拟中的纵向目标最大似然估计
In target trial emulation (TTE), marginal structural models (MSMs) can be used to characterise per-protocol treatment effects over time. The MSM parameters are often estimated by inverse probability weighting (IPW), with weights estimated by maximum likelihood. However, IPW-based estimators can be unstable in small samples and are sensitive to misspecification of the weight models. An alternative method for estimating the MSM parameters is longitudinal targeted maximum…
序贯多次随机分配试验中评估动态治疗方案的纵向—生存联合框架
Sequential multiple assignment randomized trials (SMARTs) provide a systematic framework for constructing and evaluating dynamic treatment regimens (DTRs). In clinical studies, longitudinal biomarkers are routinely collected to monitor disease progression and define treatment response. However, the integration of longitudinal biomarker data into survival analysis for DTR evaluation within a SMART remains unexplored. We propose a joint longitudinal-survival framework to…